Certara (CERT) to Release Earnings on Wednesday

Certara (NASDAQ:CERT) is expected to issue its quarterly earnings data after the market closes on Wednesday, February 26th. Analysts expect the company to announce earnings of $0.13 per share and revenue of $99.13 million for the quarter. Investors that wish to listen to the company’s conference call can do so using this link.

Certara Stock Down 2.8 %

CERT stock opened at $13.17 on Monday. Certara has a 52-week low of $9.41 and a 52-week high of $19.87. The company’s 50 day simple moving average is $12.32 and its 200-day simple moving average is $11.63. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.86 and a quick ratio of 2.86. The firm has a market capitalization of $2.12 billion, a P/E ratio of -65.85, a P/E/G ratio of 9.29 and a beta of 1.57.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on CERT shares. Barclays cut their price target on shares of Certara from $14.00 to $12.00 and set an “equal weight” rating on the stock in a report on Thursday, November 7th. Robert W. Baird cut their price target on shares of Certara from $18.00 to $13.00 and set a “neutral” rating on the stock in a report on Tuesday, November 5th. Six research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, Certara presently has an average rating of “Hold” and an average price target of $15.92.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.